Novo Nordisk A/S (NEO:NVON)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of CAD 313.69 billion. The enterprise value is 331.09 billion.

Market Cap	313.69B
Enterprise Value	331.09B

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.57%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.19B

Valuation Ratios

The trailing PE ratio is 13.15 and the forward PE ratio is 12.16.

PE Ratio	13.15
Forward PE	12.16
PS Ratio	4.68
PB Ratio	8.69
P/TBV Ratio	24.27
P/FCF Ratio	22.40
P/OCF Ratio	12.02
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.51, with an EV/FCF ratio of 23.64.

EV / Earnings	13.88
EV / Sales	4.90
EV / EBITDA	9.51
EV / EBIT	10.28
EV / FCF	23.64

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.59.

Current Ratio	0.78
Quick Ratio	0.50
Debt / Equity	0.59
Debt / EBITDA	0.62
Debt / FCF	1.52
Interest Coverage	17.27

Financial Efficiency

Return on equity (ROE) is 79.17% and return on invested capital (ROIC) is 42.53%.

Return on Equity (ROE)	79.17%
Return on Assets (ROA)	21.82%
Return on Invested Capital (ROIC)	42.53%
Return on Capital Employed (ROCE)	54.12%
Revenue Per Employee	854,449
Profits Per Employee	304,233
Employee Count	77,349
Asset Turnover	0.73
Inventory Turnover	1.20

Taxes

In the past 12 months, Novo Nordisk has paid 6.38 billion in taxes.

Income Tax	6.38B
Effective Tax Rate	21.10%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	6.93
200-Day Moving Average	n/a
Relative Strength Index (RSI)	40.76
Average Volume (20 Days)	77,352

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of CAD 66.98 billion and earned 23.85 billion in profits. Earnings per share was 5.36.

Revenue	66.98B
Gross Profit	56.43B
Operating Income	31.91B
Pretax Income	30.23B
Net Income	23.85B
EBITDA	34.20B
EBIT	31.91B
Earnings Per Share (EPS)	5.36

Balance Sheet

The company has 4.07 billion in cash and 21.31 billion in debt, giving a net cash position of -17.25 billion.

Cash & Cash Equivalents	4.07B
Total Debt	21.31B
Net Cash	-17.25B
Net Cash Per Share	n/a
Equity (Book Value)	36.09B
Book Value Per Share	8.12
Working Capital	-9.62B

Cash Flow

In the last 12 months, operating cash flow was 26.09 billion and capital expenditures -12.09 billion, giving a free cash flow of 14.00 billion.

Operating Cash Flow	26.09B
Capital Expenditures	-12.09B
Free Cash Flow	14.00B
FCF Per Share	n/a

Margins

Gross margin is 84.26%, with operating and profit margins of 47.65% and 35.61%.

Gross Margin	84.26%
Operating Margin	47.65%
Pretax Margin	45.13%
Profit Margin	35.61%
EBITDA Margin	51.06%
EBIT Margin	47.65%
FCF Margin	20.91%

Dividends & Yields

Novo Nordisk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	45.63%
Buyback Yield	0.57%
Shareholder Yield	n/a
Earnings Yield	7.60%
FCF Yield	4.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novo Nordisk has an Altman Z-Score of 7.82 and a Piotroski F-Score of 4.

Altman Z-Score	7.82
Piotroski F-Score	4